GeneDx Holdings Corp
WGS136.910USD
+5.410+4.11%
收盤 10/31, 16:00（美東）報價延遲15分鐘
3.96B總市值
1898.84本益比TTM
關於 GeneDx Holdings Corp 公司
GeneDx Holdings Corp. 是一家基因組學公司。該公司專注於提供個性化和可操作的健康見解，以指導診斷、指導治療和改善藥物發現。該公司的部門包括 GeneDx，包括 Legacy GeneDx 和 Legacy Sema4。GeneDx 部門主要提供兒科和罕見疾病診斷，重點是全外顯子組和基因組測序，以及在較小程度上提供數據和信息服務。GeneDx 利用集成的實驗室流程、軟件工具和信息學功能組合來處理含脫氧核糖核酸 (DNA) 的樣本，分析有關患者特定遺傳變異的信息併爲臨牀醫生及其患者生成測試報告。GeneDx 提供各種基因診斷測試、篩查解決方案和信息。Legacy Sema4 診斷部門提供生殖和女性健康以及軀體腫瘤診斷測試和篩查產品。
GeneDx Holdings Corp簡介
公司代碼WGS
公司名稱GeneDx Holdings Corp
上市日期Sep 04, 2020
CEOMs. Katherine A. Stueland
員工數量1000
證券類型Ordinary Share
年結日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編06902
電話18887291206
網址https://sema4.com/
公司代碼WGS
上市日期Sep 04, 2020
CEOMs. Katherine A. Stueland
GeneDx Holdings Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
股東統計
更新時間: 21 小時前
更新時間: 21 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
其他
63.74%
持股股東
持股股東
佔比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
其他
63.74%
股東類型
持股股東
佔比
Hedge Fund
36.17%
Investment Advisor/Hedge Fund
35.94%
Investment Advisor
31.04%
Corporation
10.65%
Research Firm
6.54%
Individual Investor
1.61%
Pension Fund
0.81%
Venture Capital
0.54%
Bank and Trust
0.48%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
427
31.75M
110.52%
-296.44K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Corvex Management LP
3.06M
10.65%
--
--
Aug 22, 2025
Casdin Capital, LLC
3.05M
10.6%
-461.51K
-13.16%
Aug 22, 2025
William Blair Investment Management, LLC
1.63M
5.68%
+442.41K
+37.21%
Jun 30, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.78%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.77%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.28M
4.45%
+241.28K
+23.25%
Jun 30, 2025
Pentwater Capital Management LP
1.22M
4.25%
+1.19M
+3712.50%
Jun 30, 2025
The Vanguard Group, Inc.
1.18M
4.09%
+148.96K
+14.50%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.04M
3.61%
+533.38K
+105.89%
Jun 30, 2025
UBS Financial Services, Inc.
1.00M
3.49%
+951.52K
+1895.62%
Jun 30, 2025
查看更多
持股ETF
更新時間: 10月6日 週一
更新時間: 10月6日 週一
機構名稱
佔比
Global X Genomics & Biotechnology ETF
3.85%
SPDR S&P Health Care Services ETF
3.59%
Innovator IBD 50 Fund ETF
3.05%
Alger Mid Cap 40 ETF
2.05%
Harbor Health Care ETF
2.05%
Simplify Health Care ETF
1.32%
Franklin Genomic Advancements ETF
1.23%
Main Thematic Innovation ETF
1.02%
Hypatia Women CEO ETF
0.87%
ARK Genomic Revolution ETF
0.83%
查看更多
Global X Genomics & Biotechnology ETF
佔比3.85%
SPDR S&P Health Care Services ETF
佔比3.59%
Innovator IBD 50 Fund ETF
佔比3.05%
Alger Mid Cap 40 ETF
佔比2.05%
Harbor Health Care ETF
佔比2.05%
Simplify Health Care ETF
佔比1.32%
Franklin Genomic Advancements ETF
佔比1.23%
Main Thematic Innovation ETF
佔比1.02%
Hypatia Women CEO ETF
佔比0.87%
ARK Genomic Revolution ETF
佔比0.83%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
公告日期
類型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
